InsiderPulse| Date | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | Susi Roger E. | Director & CEO, President, Chairman | Sale | 3,750 | $86.23 | $323K | 2.19M | View ↗ | |
| 2026-04-27 | Susi Roger E. | Director & CEO, President, Chairman | Sale | 3,750 | $89.16 | $334K | 2.20M | View ↗ | |
| 2026-04-21 | Susi Roger E. | Director & CEO, President, Chairman | Sale | 2,500 | $90.94 | $227K | 2.20M | View ↗ | |
| 2026-04-20 | Susi Roger E. | Director & CEO, President, Chairman | Sale | 5,000 | $93.36 | $467K | 2.21M | View ↗ | |
| 2026-04-14 | Susi Roger E. | Director & CEO, President, Chairman | Sale | 2,500 | $93.84 | $235K | 2.21M | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $83.8M+14.4% | $73.2M+11.7% | $65.6M+23.0% | $53.3M |
| Cost of revenue | $19.5M+15.4% | $16.9M+9.7% | $15.4M+28.1% | $12.0M |
| Gross profit | $64.3M+14.2% | $56.4M+12.3% | $50.2M+21.5% | $41.3M |
| General and administrative | $17.8M+11.6% | $15.9M+5.4% | $15.1M+41.4% | $10.7M |
| Sales and marketing | $17.4M+11.6% | $15.6M+28.6% | $12.1M-4.2% | $12.7M |
| Research and development | $3.0M+5.0% | $2.8M-0.9% | $2.9M+25.5% | $2.3M |
| Total operating expenses | $38.2M+11.0% | $34.4M+14.1% | $30.1M+17.4% | $25.7M |
| Income from operations | $26.1M+19.0% | $22.0M+9.6% | $20.0M+28.2% | $15.6M |
| Other income, net | $2.2M-4.2% | $2.3M+35.7% | $1.7M+207.9% | $553K |
| Income before provision for income taxes | $28.4M+16.8% | $24.3M+11.7% | $21.7M+34.3% | $16.2M |
| Provision for income tax expense | $5.9M+16.7% | $5.0M+10.9% | $4.5M+35.6% | $3.4M |
| Net income | $22.5M+16.9% | $19.2M+11.9% | $17.2M+34.0% | $12.8M |
| Basic (in dollars per share) | $2K+16.4% | $2K+111664.7% | $1.36+33.3% | $1.02 |
| Diluted (in dollars per share) | $2K+16.7% | $2K+111011.1% | $1.35+32.4% | $1.02 |
| Basic (in shares) | $12.7M+0.4% | $12.7M+0.5% | $12.6M+0.3% | $12.6M |
| Diluted (in shares) | $12.9M+0.5% | $12.8M+0.5% | $12.7M+0.7% | $12.6M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
iRadimed Q1 2026 Earnings Preview
How The Evolving Story For IRADIMED (IRMD) Is Shaping Analyst Targets And Fair Value
Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors.
Riverwater Micro Opportunities Strategy Q1 2026 Portfolio Activity